Feb 27 |
ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
|
Feb 15 |
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
|
Feb 8 |
ABVC BioPharma to acquire real estate worth $2.96M in Taiwan
|
Feb 8 |
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
|
Jan 25 |
Looking Into ABVC BioPharma's Recent Short Interest
|
Jan 12 |
ABVC BioPharma files to sell 10.4M shares for holders
|
Jan 4 |
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Jan 3 |
ABVC Biopharma and unit receive $460M as first milestone payment; shares jump
|
Jan 3 |
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
|
Dec 7 |
ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study
|